Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2009
DOI: 10.1093/bjaceaccp/mkp005
|View full text |Cite
|
Sign up to set email alerts
|

Management of cardiac disease in pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
28
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(29 citation statements)
references
References 8 publications
(9 reference statements)
0
28
0
1
Order By: Relevance
“…This increase in cardiac output is accomplished by an increase in ventricular end-diastolic volume, wall mass, and contractility, which creates an increase in stroke volume and heart rate. Due to these alterations, pregnant women are placed at higher risk for developing comorbidities such as cardiac arrhythmias that range from benign to life threatening [4, 5]. …”
Section: Discussionmentioning
confidence: 99%
“…This increase in cardiac output is accomplished by an increase in ventricular end-diastolic volume, wall mass, and contractility, which creates an increase in stroke volume and heart rate. Due to these alterations, pregnant women are placed at higher risk for developing comorbidities such as cardiac arrhythmias that range from benign to life threatening [4, 5]. …”
Section: Discussionmentioning
confidence: 99%
“…10,11 However, vaginal delivery causes smaller shifts in blood volume and fewer complications including reduced blood loss, infection and thromboembolic events 12 when compared to caesarean delivery. An assisted second stage helps in reduced cardiac work and decreased maternal expulsive efforts.…”
Section: Route Of Deliverymentioning
confidence: 99%
“…At the same time vascular peripheral resistance reduces and heart rate increases. 2 On the other hand, there is an increased level of clotting cascade factors resulting in a higher generation of thrombin 14 while anticoagulant factors such as protein S and C reduce their activity. Moreover there is a decreased production of tissue plasminogen activator.…”
Section: Brief Overview On Cardiovascular Physiology During Pregnancymentioning
confidence: 99%